Oruka Therapeutics

Oruka Therapeutics prices upsized $700M public offering at $72.50 per share MSN

Oruka Therapeutics prices $700M stock offering at $72.50/share Investing.com

Oruka Therapeutics, Inc. Prices Upsized Public Offering of 9.66 Million Shares at $72.50 Per Share Quiver Quantitative

Biotech Oruka locks in $700M cash raise at $72.50 a share Stock Titan

Oruka Therapeutics (ORKA) Hits Record High on Stellar Clinical Trial Result Yahoo Finance

Oruka Therapeutics: 'Strong Buy' On Half-Life Extended IL-23p19 Inhibitor ORKA-001 Seeking Alpha

Oruka surges as long-acting psoriasis drug shows early promise BioPharma Dive

This Is Why Oruka Therapeutics Stock (ORKA) Soared Today TipRanks

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC PR Newswire NEW YORK, June 5, 2024 NEW YORK , June 5, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka PR Newswire MILWAUKEE, June 4, 2024 MILWAUKEE , June 4, 2024 /PRNewswire/ -- Adem

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF PR Newswire NEW YORK, May 23, 2024 NEW YORK , May 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law f

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm PR Newswire NEW YORK, May 22, 2024 NEW YORK , May 22, 2024 /PRNewswire/ -- Kuehn Law , PLLC, a shareholder litigation la

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (Nasdaq

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO PR Newswire NEW YORK, April 10, 2024 NEW YORK , April 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO PR Newswire NEW YORK, April 9, 2024 NEW YORK , April 9, 2024 /PRNewswire/ -- Montever

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm PR Newswire NEW YORK, April 5, 2024 NEW YORK , April 5, 2024 /PRNewswire/ -- Kuehn Law , PLLC, a shareholder litigation l